Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Eye | 2 | 2021 | 374 | 0.77 | Why? |
| Ebolavirus | 5 | 2019 | 834 | 0.77 | Why? |
| Hemorrhagic Fever, Ebola | 5 | 2019 | 1475 | 0.63 | Why? |
| Zika Virus Infection | 3 | 2018 | 1920 | 0.61 | Why? |
| Measles virus | 1 | 2017 | 194 | 0.59 | Why? |
| Zika Virus | 3 | 2018 | 1924 | 0.43 | Why? |
| RNA, Viral | 13 | 2021 | 32276 | 0.39 | Why? |
| Measles | 1 | 2017 | 608 | 0.39 | Why? |
| Viral Matrix Proteins | 1 | 2017 | 1243 | 0.38 | Why? |
| Sierra Leone | 3 | 2017 | 267 | 0.37 | Why? |
| Leukocytes, Mononuclear | 1 | 2018 | 2115 | 0.36 | Why? |
| Antigens, Viral | 3 | 2021 | 6298 | 0.33 | Why? |
| Interferons | 1 | 2018 | 2885 | 0.30 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.28 | Why? |
| Arthritis, Rheumatoid | 1 | 2018 | 2043 | 0.27 | Why? |
| Vero Cells | 10 | 2021 | 14117 | 0.25 | Why? |
| Semen | 2 | 2018 | 550 | 0.23 | Why? |
| Gorilla gorilla | 1 | 2021 | 53 | 0.22 | Why? |
| Lipid Droplets | 1 | 2021 | 75 | 0.22 | Why? |
| Stromal Cells | 1 | 2021 | 105 | 0.21 | Why? |
| Mass Screening | 1 | 2021 | 8005 | 0.21 | Why? |
| DEAD-box RNA Helicases | 1 | 2021 | 99 | 0.21 | Why? |
| Macaca | 2 | 2021 | 388 | 0.21 | Why? |
| Adenovirus Vaccines | 1 | 2021 | 103 | 0.20 | Why? |
| Virus Shedding | 3 | 2021 | 5834 | 0.19 | Why? |
| Fluorescent Antibody Technique, Indirect | 1 | 2020 | 393 | 0.19 | Why? |
| Interleukin-9 | 1 | 2018 | 29 | 0.19 | Why? |
| Poxviridae Infections | 1 | 2018 | 31 | 0.18 | Why? |
| Flavivirus Infections | 1 | 2019 | 81 | 0.18 | Why? |
| Orthopoxvirus | 1 | 2018 | 29 | 0.18 | Why? |
| Osteoblasts | 1 | 2018 | 87 | 0.17 | Why? |
| West Nile virus | 1 | 2019 | 206 | 0.17 | Why? |
| Neutralization Tests | 2 | 2021 | 6698 | 0.16 | Why? |
| Flavivirus | 1 | 2019 | 182 | 0.16 | Why? |
| Disease Outbreaks | 6 | 2019 | 27595 | 0.16 | Why? |
| Monkey Diseases | 1 | 2018 | 190 | 0.16 | Why? |
| Lipid Metabolism | 1 | 2021 | 572 | 0.15 | Why? |
| Conjunctivitis | 1 | 2020 | 318 | 0.15 | Why? |
| Real-Time Polymerase Chain Reaction | 6 | 2021 | 11367 | 0.15 | Why? |
| Sensitivity and Specificity | 7 | 2021 | 22971 | 0.15 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.15 | Why? |
| Adenoviridae | 1 | 2021 | 1151 | 0.14 | Why? |
| Coronaviridae | 1 | 2021 | 923 | 0.14 | Why? |
| Chikungunya virus | 1 | 2018 | 339 | 0.14 | Why? |
| Virus Replication | 4 | 2021 | 14331 | 0.14 | Why? |
| Italy | 9 | 2021 | 38444 | 0.14 | Why? |
| Measles Vaccine | 1 | 2017 | 301 | 0.13 | Why? |
| Point-of-Care Systems | 2 | 2017 | 2955 | 0.13 | Why? |
| Chikungunya Fever | 1 | 2018 | 345 | 0.13 | Why? |
| Animals | 14 | 2021 | 78931 | 0.13 | Why? |
| Viral Tropism | 1 | 2021 | 1329 | 0.12 | Why? |
| Antibodies, Viral | 8 | 2021 | 51949 | 0.12 | Why? |
| Virion | 1 | 2021 | 1444 | 0.12 | Why? |
| Nasopharynx | 3 | 2020 | 10224 | 0.12 | Why? |
| Clinical Laboratory Techniques | 6 | 2020 | 23402 | 0.12 | Why? |
| Interleukin-8 | 1 | 2018 | 964 | 0.12 | Why? |
| ROC Curve | 2 | 2021 | 6024 | 0.11 | Why? |
| Anti-Retroviral Agents | 1 | 2020 | 1099 | 0.11 | Why? |
| Cells, Cultured | 2 | 2021 | 5835 | 0.11 | Why? |
| Dengue Virus | 1 | 2018 | 910 | 0.11 | Why? |
| Travel | 2 | 2020 | 7220 | 0.10 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.10 | Why? |
| Myocardium | 1 | 2021 | 2323 | 0.09 | Why? |
| Phylogeny | 4 | 2020 | 13341 | 0.09 | Why? |
| Disease Reservoirs | 1 | 2018 | 1672 | 0.09 | Why? |
| Drug Evaluation, Preclinical | 1 | 2020 | 3347 | 0.09 | Why? |
| Respiratory System | 1 | 2021 | 3213 | 0.09 | Why? |
| Humans | 31 | 2021 | 930598 | 0.09 | Why? |
| Point-of-Care Testing | 1 | 2021 | 2782 | 0.09 | Why? |
| Reagent Kits, Diagnostic | 1 | 2017 | 2149 | 0.08 | Why? |
| Lung | 3 | 2021 | 31049 | 0.08 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.08 | Why? |
| Feces | 1 | 2020 | 4235 | 0.08 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.08 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.08 | Why? |
| Immunoglobulin M | 3 | 2018 | 9091 | 0.07 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.07 | Why? |
| Dengue | 1 | 2018 | 1565 | 0.07 | Why? |
| Blood Donors | 1 | 2019 | 2956 | 0.07 | Why? |
| Male | 19 | 2021 | 367725 | 0.07 | Why? |
| Female | 16 | 2021 | 380317 | 0.07 | Why? |
| Receptors, Virus | 1 | 2021 | 5659 | 0.07 | Why? |
| Antibodies, Neutralizing | 5 | 2021 | 25288 | 0.07 | Why? |
| Heart Diseases | 1 | 2021 | 3503 | 0.07 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.07 | Why? |
| Models, Biological | 1 | 2021 | 4907 | 0.07 | Why? |
| Virus Internalization | 1 | 2021 | 7921 | 0.06 | Why? |
| Poly-ADP-Ribose Binding Proteins | 1 | 2021 | 47 | 0.06 | Why? |
| RNA Recognition Motif Proteins | 1 | 2021 | 49 | 0.06 | Why? |
| Eukaryotic Initiation Factor-2 | 1 | 2021 | 81 | 0.06 | Why? |
| Antiviral Agents | 4 | 2021 | 41703 | 0.05 | Why? |
| Spheroids, Cellular | 1 | 2021 | 124 | 0.05 | Why? |
| Cell Line | 3 | 2021 | 12040 | 0.05 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.05 | Why? |
| DNA Helicases | 1 | 2021 | 203 | 0.05 | Why? |
| Interleukin-6 | 1 | 2018 | 7522 | 0.05 | Why? |
| Adult | 11 | 2021 | 244371 | 0.05 | Why? |
| Aged | 9 | 2021 | 215776 | 0.05 | Why? |
| Oxazines | 1 | 2020 | 279 | 0.05 | Why? |
| HIV Integrase Inhibitors | 1 | 2020 | 173 | 0.05 | Why? |
| Immunoglobulin G | 5 | 2021 | 21571 | 0.05 | Why? |
| Reverse Transcriptase Inhibitors | 1 | 2020 | 309 | 0.05 | Why? |
| Cytopathogenic Effect, Viral | 1 | 2021 | 635 | 0.05 | Why? |
| Diagnostic Tests, Routine | 2 | 2020 | 2643 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2019 | 6817 | 0.05 | Why? |
| Africa, Western | 1 | 2019 | 363 | 0.04 | Why? |
| Protein Engineering | 1 | 2021 | 536 | 0.04 | Why? |
| Cell Death | 1 | 2020 | 536 | 0.04 | Why? |
| RNA Helicases | 1 | 2021 | 413 | 0.04 | Why? |
| Genome, Viral | 1 | 2020 | 13157 | 0.04 | Why? |
| Imatinib Mesylate | 1 | 2020 | 327 | 0.04 | Why? |
| Heterocyclic Compounds, 3-Ring | 1 | 2020 | 275 | 0.04 | Why? |
| HEK293 Cells | 2 | 2021 | 8394 | 0.04 | Why? |
| Piperazines | 1 | 2020 | 445 | 0.04 | Why? |
| Fibrosis | 1 | 2021 | 800 | 0.04 | Why? |
| HeLa Cells | 1 | 2021 | 1303 | 0.04 | Why? |
| Lysosomes | 1 | 2020 | 416 | 0.04 | Why? |
| Sequence Analysis | 1 | 2019 | 496 | 0.04 | Why? |
| Coronaviridae Infections | 1 | 2021 | 442 | 0.04 | Why? |
| Culicidae | 1 | 2019 | 239 | 0.04 | Why? |
| Tenofovir | 1 | 2020 | 449 | 0.04 | Why? |
| Transgender Persons | 1 | 2020 | 322 | 0.04 | Why? |
| Body Fluids | 1 | 2020 | 451 | 0.04 | Why? |
| RNA, Small Interfering | 1 | 2021 | 817 | 0.04 | Why? |
| CD4 Lymphocyte Count | 1 | 2020 | 1517 | 0.04 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.04 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.04 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.04 | Why? |
| Pyridones | 1 | 2020 | 738 | 0.04 | Why? |
| HIV Infections | 1 | 2020 | 11620 | 0.03 | Why? |
| Aedes | 1 | 2018 | 380 | 0.03 | Why? |
| Genetic Vectors | 1 | 2021 | 1600 | 0.03 | Why? |
| Thailand | 1 | 2018 | 1155 | 0.03 | Why? |
| Pharynx | 1 | 2020 | 1544 | 0.03 | Why? |
| Polymerase Chain Reaction | 2 | 2019 | 6740 | 0.03 | Why? |
| Kinetics | 1 | 2021 | 3238 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2021 | 3608 | 0.03 | Why? |
| Limit of Detection | 1 | 2020 | 2698 | 0.03 | Why? |
| Base Sequence | 1 | 2020 | 3581 | 0.03 | Why? |
| Child | 2 | 2020 | 70012 | 0.03 | Why? |
| Vaccination | 1 | 2017 | 19050 | 0.03 | Why? |
| Sentinel Surveillance | 1 | 2019 | 1093 | 0.03 | Why? |
| Public Health | 1 | 2017 | 16359 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 2309 | 0.03 | Why? |
| Host-Pathogen Interactions | 2 | 2021 | 11041 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Protein Kinase Inhibitors | 1 | 2020 | 1585 | 0.03 | Why? |
| Mice, Inbred BALB C | 1 | 2021 | 5814 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Phenotype | 1 | 2021 | 4037 | 0.03 | Why? |
| Proteomics | 1 | 2021 | 2481 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2021 | 2654 | 0.02 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2018 | 2830 | 0.02 | Why? |
| Binding Sites | 1 | 2021 | 6201 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2021 | 6543 | 0.02 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 3633 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| Models, Molecular | 1 | 2021 | 7616 | 0.02 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.02 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2020 | 4849 | 0.02 | Why? |
| Genetic Variation | 1 | 2020 | 3919 | 0.02 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.02 | Why? |
| Child, Preschool | 2 | 2020 | 36283 | 0.02 | Why? |
| Protein Binding | 1 | 2021 | 11430 | 0.02 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2019 | 3388 | 0.02 | Why? |
| Molecular Diagnostic Techniques | 1 | 2020 | 4239 | 0.02 | Why? |
| Algorithms | 1 | 2021 | 7346 | 0.02 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.02 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.02 | Why? |
| Mice | 1 | 2021 | 21357 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.01 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.01 | Why? |
| SARS Virus | 1 | 2021 | 13021 | 0.01 | Why? |
| Infant | 1 | 2020 | 30274 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2021 | 12361 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.01 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
Colavita's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(191)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(330)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_